LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 7786 | 10362 | 0.7517 | 0.8723 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 1665 | 10362 | 0.1607 | 0.3117 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 72 | hr | 513 | 570 | 10362 | 0.0550 | 0.0244 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 675 | 10362 | 0.0651 | 0.0649 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 783 | 10362 | 0.0755 | 0.1021 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 737 | 10362 | 0.0711 | 0.0868 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 880 | 10362 | 0.0848 | 0.1292 |
MCF 10A | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 910 | 10362 | 0.0878 | 0.1410 |
MCF 10A | Trametinib | 10 | uM | LJP5 | 72 | hr | 513 | 1020 | 10362 | 0.0985 | 0.1717 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 513 | 714 | 10473 | 0.0682 | 0.0784 |
MCF 10A | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 513 | 607 | 10473 | 0.0580 | 0.0382 |
MCF 10A | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 513 | 536 | 10473 | 0.0512 | 0.0098 |
MCF 10A | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 513 | 543 | 10473 | 0.0519 | 0.0128 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 513 | 431 | 10473 | 0.0412 | -0.0395 |
MCF 10A | Omipalisib | 10 | uM | LJP6 | 72 | hr | 513 | 397 | 10473 | 0.0379 | -0.0574 |
MCF 10A | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10062 | 10362 | 0.9710 | 0.9864 |
MCF 10A | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 513 | 8404 | 10362 | 0.8110 | 0.9057 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 513 | 5559 | 10362 | 0.5359 | 0.7291 |
MCF 10A | Buparlisib | 1.11 | uM | LJP5 | 72 | hr | 513 | 1357 | 10362 | 0.1309 | 0.2500 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 513 | 386 | 10362 | 0.0372 | -0.0664 |
MCF 10A | Buparlisib | 10 | uM | LJP5 | 72 | hr | 513 | 331 | 10362 | 0.0320 | -0.0963 |
MCF 10A | XL147 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10693 | 10362 | 1.0321 | 1.0145 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10166 | 10362 | 0.9807 | 0.9906 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9954 | 10362 | 0.9604 | 0.9814 |
MCF 10A | XL147 | 1.11 | uM | LJP5 | 72 | hr | 513 | 9726 | 10362 | 0.9387 | 0.9710 |